Načítá se...

P14.63 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

BACKGROUND: Despite various clinical phase 3 trials, survival for the most common brain tumour, glioblastoma (GBM), has not improved since 2005. Alternating electric fields with low-intensity and intermediate frequency, known as tumor treating fields (TTFields) were shown to inhibit cancer cell divi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M G
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795960/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.298
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!